Rudolf Valenta Selected Research

Rudolf Valenta Research Topics

Disease

177	Hypersensitivity (Allergy) 03/2024 - 01/2002
46	Asthma (Bronchial Asthma) 11/2023 - 01/2002
45	Seasonal Allergic Rhinitis (Hay Fever) 12/2023 - 01/2002
39	Inflammation (Inflammations) 02/2023 - 09/2003
25	Infections 10/2023 - 05/2009
22	Atopic Dermatitis (Atopic Eczema) 01/2023 - 04/2002
15	Food Hypersensitivity (Food Allergy) 10/2023 - 05/2002
14	COVID-19 04/2023 - 01/2020
11	Anaphylaxis (Anaphylactic Shock) 05/2023 - 03/2004
9	Rhinitis 11/2023 - 05/2015
8	Hepatitis B 05/2022 - 06/2011
6	Allergic Rhinitis 01/2022 - 02/2007
6	Leukemia 01/2022 - 02/2007
5	Communicable Diseases (Infectious Diseases) 01/2020 - 03/2002
4	Skin Diseases (Skin Disease) 01/2023 - 05/2004
4	Milk Hypersensitivity (Milk Allergy) 12/2022 - 06/2009
4	Neoplasms (Cancer) 11/2022 - 01/2003
4	Conjunctivitis 06/2022 - 01/2006
4	Dust Mite Allergy 01/2016 - 01/2008
3	Celiac Disease (Celiac Sprue) 02/2022 - 10/2013
3	Immune System Diseases (Immune Disorders) 01/2021 - 05/2016
3	Respiratory Sounds (Crackle) 01/2021 - 01/2018
3	Respiratory Tract Diseases (Respiratory Tract Disease) 06/2020 - 05/2009
3	Wheat Hypersensitivity (Wheat Allergy) 01/2018 - 01/2009
2	Immediate Hypersensitivity 05/2023 - 03/2002
2	Pneumonia (Pneumonitis) 01/2023 - 05/2018
2	Dermatitis 06/2022 - 09/2013
2	Peanut Hypersensitivity (Peanut Allergy) 01/2021 - 01/2017
2	Nasal Polyps (Nasal Polyp) 01/2021 - 01/2016
2	Eczema 01/2017 - 01/2017
2	Parasitic Diseases (Parasitic Disease) 01/2016 - 01/2003
2	HIV Infections (HIV Infection) 01/2015 - 01/2014
2	Skin Manifestations 01/2014 - 10/2002
2	Virus Diseases (Viral Diseases) 01/2011 - 05/2009
1	Nasal Obstruction 11/2023

Drug/Important Bio-Agent (IBA)

191	AllergensIBA 03/2024 - 01/2002
167	Immunoglobulin E (IgE)IBA 03/2024 - 01/2002
64	VaccinesIBA 10/2023 - 01/2002
40	AntibodiesIBA 10/2023 - 01/2002
38	Peptides (Polypeptides)IBA 12/2023 - 12/2004
37	Immunoglobulin G (IgG)IBA 12/2023 - 08/2002
29	Proteins (Proteins, Gene)FDA Link 10/2023 - 08/2004
24	AntigensIBA 11/2022 - 03/2002
20	EpitopesIBA 10/2022 - 05/2004
10	CytokinesIBA 11/2023 - 05/2004
10	P-2 (P 2)IBA 01/2019 - 01/2002
8	Biomarkers (Surrogate Marker)IBA 06/2022 - 04/2012
6	Immunoglobulin A (IgA)IBA 12/2021 - 11/2005
5	Recombinant Fusion ProteinsIBA 05/2022 - 04/2013
5	Carrier Proteins (Binding Protein)IBA 05/2022 - 05/2009
5	ParvalbuminsIBA 06/2017 - 05/2002
5	AutoantibodiesIBA 09/2008 - 04/2002
4	Pyridinolcarbamate (P23)IBA 01/2022 - 04/2013
4	Membrane Proteins (Integral Membrane Proteins)IBA 09/2020 - 05/2009
4	VenomsIBA 02/2020 - 06/2010
4	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 11/2017 - 05/2005
4	Complementary DNA (cDNA)IBA 01/2014 - 07/2005
4	CalciumIBA 09/2013 - 02/2002
4	AutoantigensIBA 03/2009 - 10/2002
3	Monoclonal AntibodiesIBA 03/2023 - 06/2006
3	Immunoglobulins (Immunoglobulin)IBA 03/2023 - 09/2013
3	ragweed pollenIBA 02/2023 - 01/2018
3	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2023 - 01/2014
3	Dermatophagoides pteronyssinus antigen p 2IBA 01/2023 - 05/2008
3	CarbohydratesIBA 07/2022 - 04/2011
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2015
3	InterferonsIBA 01/2021 - 01/2018
3	Blocking AntibodiesIBA 06/2017 - 09/2003
3	Antigen-Antibody Complex (Immune Complex)IBA 03/2017 - 03/2009
3	Interleukin-4 (Interleukin 4)IBA 01/2017 - 08/2005
3	Recombinant DNA (Recombinant DNA Research)IBA 02/2016 - 04/2011
3	Combined VaccinesIBA 08/2012 - 08/2002
3	Peptide Hydrolases (Proteases)FDA Link 03/2009 - 05/2006
2	Interleukin-13IBA 11/2023 - 11/2022
2	Lactalbumin (alpha-Lactalbumin)IBA 05/2023 - 06/2010
2	Dendrimers (Dendrons)IBA 01/2023 - 01/2021
2	Small Interfering RNA (siRNA)IBA 01/2023 - 01/2021
2	Glutens (Glutelin)IBA 02/2022 - 12/2015
2	GliadinIBA 02/2022 - 12/2015
2	Omalizumab (Xolair)FDA Link 01/2022 - 03/2017
2	Fibronectins (Fibronectin)IBA 01/2022 - 07/2011
2	anti-IgE antibodiesIBA 01/2022 - 03/2017
2	Indicators and Reagents (Reagents)IBA 01/2020 - 10/2003
2	Wasp Venoms (Venom, Wasp)IBA 01/2018 - 06/2010
2	Dermatophagoides pteronyssinus antigen p 1IBA 01/2017 - 08/2012
2	APTIBA 01/2017 - 02/2016
2	Synthetic Vaccines (Recombinant Vaccines)IBA 02/2016 - 04/2007
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 02/2016 - 11/2010
2	ProteomeIBA 03/2015 - 01/2015
2	purothioninIBA 01/2014 - 10/2013
2	Aligeron (AS 2)IBA 06/2010 - 08/2004
2	nascent-polypeptide-associated complexIBA 06/2008 - 10/2002
2	Tryptases (Tryptase)IBA 01/2008 - 05/2006
2	DNA VaccinesIBA 09/2006 - 01/2003
1	3-N-butyl-4,5-dihydrophthalide (NBPA)IBA 12/2023
1	Lactoglobulins (beta-Lactoglobulin)FDA Link 05/2023

Therapy/Procedure

63	Immunotherapy 11/2023 - 01/2002
28	Therapeutics 03/2023 - 02/2002
5	Precision Medicine 02/2023 - 08/2017
3	Cell- and Tissue-Based Therapy (Cell Therapy) 03/2024 - 01/2011